SBH
NUVA

Segall Bryant & Hamill’s NuVasive, Inc. NUVA Stock Holding History

Segall Bryant & Hamill’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-63,735
Closed -$3.1M – 760
2020
Q3 		$3.1M Buy
63,735
+9,948
+18% +$536K 0.04% 329
2020
Q2 		$2.99M Buy
53,787
+1,190
+2% +$68.8K 0.05% 284
2020
Q1 		$2.66M Buy
52,597
+7,765
+17% +$521K 0.05% 295
2019
Q4 		$3.47M Sell
44,832
-3,110
-6% -$220K 0.05% 308
2019
Q3 		$3.04M Buy
47,942
+308
+0.6% +$19.3K 0.05% 340
2019
Q2 		$2.79M Sell
47,634
-15,268
-24% -$901K 0.04% 351
2019
Q1 		$3.57M Sell
62,902
-23,515
-27% -$1.25M 0.06% 319
2018
Q4 		$4.28M Buy
+86,417
New +$5.2M 0.07% 284
2014
Q3 		– Sell
-185,916
Closed -$6.61M – 560
2014
Q2 		$6.61M Buy
185,916
+2,790
+2% +$95.5K 0.16% 174
2014
Q1 		$7.03M Sell
183,126
-94,942
-34% -$3.49M 0.17% 170
2013
Q4 		$8.99M Sell
278,068
-22,230
-7% -$668K 0.21% 143
2013
Q3 		$7.35M Sell
300,298
-31,763
-10% -$782K 0.18% 158
2013
Q2 		$8.23M Buy
+332,061
New +$7.27M 0.22% 146

Other funds holding NUVA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACA
Anchor Capital Advisors Boston, Massachusetts $3.51B AUM 16.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Segall Bryant & Hamill's NUVA Position: Q4 2020 in Review

Segall Bryant & Hamill sold out of NuVasive, Inc. (NUVA) in Q4 2020, closing a stake of 63,735 shares — an estimated $3.1M sold.

Segall Bryant & Hamill first reported a position in NUVA in Q2 2013 and held it in 13 quarters. The position peaked at $8.99M in Q4 2013. 280 funds tracked by Wall St. Rank hold NUVA as of Q4 2020.

  • Segall Bryant & Hamill reported no remaining NuVasive, Inc. position as of Q4 2020 after selling out during the quarter.
  • Segall Bryant & Hamill sold 63,735 NuVasive, Inc. shares in Q4 2020, an estimated $3.1M.
  • Segall Bryant & Hamill first reported a position in NuVasive, Inc. in Q2 2013 and held it in 13 quarters.
  • Segall Bryant & Hamill's NuVasive, Inc. position peaked at $8.99M in Q4 2013.
  • 280 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2020.

Based on Segall Bryant & Hamill's 13F filing for Q4 2020, filed 12 Feb 2021.